Last updated: 13 May 2022 at 6:15pm EST

Francis Cuss Net Worth




The estimated Net Worth of Francis M Cuss is at least $8.09 Million dollars as of 20 July 2018. Francis Cuss owns over 10,000 units of Rubius Therapeutics Inc stock worth over $830 and over the last 14 years he sold RUBY stock worth over $7,775,501. In addition, he makes $314,285 as Independent Director at Rubius Therapeutics Inc.

Francis Cuss RUBY stock SEC Form 4 insiders trading

Francis has made over 27 trades of the Rubius Therapeutics Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of RUBY stock worth $230,000 on 20 July 2018.

The largest trade he's ever made was exercising 147,618 units of Rubius Therapeutics Inc stock on 30 August 2012 worth over $3,009,931. On average, Francis trades about 22,296 units every 75 days since 2011. As of 20 July 2018 he still owns at least 10,000 units of Rubius Therapeutics Inc stock.

You can see the complete history of Francis Cuss stock trades at the bottom of the page.





Francis Cuss biography

Dr. Francis M. Cuss serves as Independent Director of the Company. Dr. Cuss is currently retired from full-time operational roles. Previously, he served as the Executive Vice President, Chief Scientific Officer and Head of Research and Development of Bristol Myers Squibb Co., a pharmaceutical company, from July 2013 to March 2017, and as the Senior Vice President and Head of Research of Bristol Myers Squibb from April 2010 to June 2013. Since September 2017, Dr. Cuss has served on the board of directors of Novo Holdings A/S and since July 2019, Dr. Cuss has served on the board of directors of Glympse Bio, Inc. Dr. Cuss also currently serves on the Advisory Committee of the Director of the National Institutes of Health. Dr. Cuss received a B.A./M.A. in natural sciences and an M.B., B.Chir. in medicine from Cambridge University. Cuss' broad experience in pharmaceutical research, clinical development and executive management within globally-operating biopharmaceutical companies make him qualified to serve on our board of directors.

What is the salary of Francis Cuss?

As the Independent Director of Rubius Therapeutics Inc, the total compensation of Francis Cuss at Rubius Therapeutics Inc is $314,285. There are 10 executives at Rubius Therapeutics Inc getting paid more, with Pablo Cagnoni having the highest compensation of $1,721,130.



How old is Francis Cuss?

Francis Cuss is 65, he's been the Independent Director of Rubius Therapeutics Inc since 2018. There are 2 older and 16 younger executives at Rubius Therapeutics Inc. The oldest executive at Rubius Therapeutics Inc is Michael Rosenblatt, 69, who is the Independent Director.

What's Francis Cuss's mailing address?

Francis's mailing address filed with the SEC is C/O RUBIUS THERAPEUTICS, INC., 399 BINNEY STREET, SUITE 300, CAMBRIDGE, MA, 02139.

Insiders trading at Rubius Therapeutics Inc

Over the last 6 years, insiders at Rubius Therapeutics Inc have traded over $2,165,279 worth of Rubius Therapeutics Inc stock and bought 305,000 units worth $6,624,680 . The most active insiders traders include Noubar Afeyan, Roger Pomerantz, and Robert Langer. On average, Rubius Therapeutics Inc executives and independent directors trade stock every 51 days with the average trade being worth of $2,709. The most recent stock trade was executed by Dannielle Appelhans on 24 February 2023, trading 10,385 units of RUBY stock currently worth $1,350.



What does Rubius Therapeutics Inc do?

developing a novel enucleated cell (ecell)(tm) therapy platform for unmet medical needs. founded by flagship venturelabs.



What does Rubius Therapeutics Inc's logo look like?

Rubius Therapeutics Inc logo

Complete history of Francis Cuss stock trades at Bristol-Myers Squibb Co and Rubius Therapeutics Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
20 Jul 2018 Francis M Cuss
Director
Buy 10,000 $23.00 $230,000
20 Jul 2018
10,000
10 Mar 2017 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 66,726 $58.32 $3,891,460
10 Mar 2017
346,769
1 Jul 2016 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 3,655 $73.78 $269,666
1 Jul 2016
291,627
10 Mar 2016 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 37,143 $64.94 $2,412,066
10 Mar 2016
300,491
6 Mar 2016 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 3,010 $64.71 $194,777
6 Mar 2016
269,043
16 Mar 2015 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Sale 114,666 $67.81 $7,775,501
16 Mar 2015
266,033
10 Mar 2015 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 8,019 $65.53 $525,485
10 Mar 2015
269,160
6 Mar 2015 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 3,009 $65.12 $195,946
6 Mar 2015
261,937
2 Mar 2015 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 23,803 $62.30 $1,482,927
2 Mar 2015
270,105
2 Mar 2015 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 3,703 $62.30 $230,697
2 Mar 2015
245,358
2 Nov 2014 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 6,666 $58.19 $387,895
2 Nov 2014
245,112
16 Sep 2014 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 63,667 $25.17 $1,602,498
16 Sep 2014
302,113
10 Mar 2014 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 2,739 $56.14 $153,767
10 Mar 2014
239,268
6 Mar 2014 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 3,010 $55.56 $167,236
6 Mar 2014
237,106
3 Mar 2014 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 47,953 $53.49 $2,565,006
3 Mar 2014
254,899
18 Feb 2014 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 38,667 $28.11 $1,086,929
18 Feb 2014
237,037
2 Nov 2013 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 6,666 $52.48 $349,832
2 Nov 2013
201,827
13 Mar 2013 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 84,952 $23.80 $2,021,858
13 Mar 2013
264,874
7 Mar 2013 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 45,017 $37.53 $1,689,488
7 Mar 2013
197,975
3 Mar 2013 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 3,753 $37.15 $139,424
3 Mar 2013
154,351
2 Nov 2012 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 6,668 $33.18 $221,244
2 Nov 2012
153,689
30 Aug 2012 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 147,618 $20.39 $3,009,931
30 Aug 2012
265,211
6 Mar 2012 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 17,866 $32.33 $577,608
6 Mar 2012
124,524
1 Mar 2012 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 14,624 $32.64 $477,327
1 Mar 2012
107,763
4 Mar 2011 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 5,476 $26.43 $144,731
4 Mar 2011
98,081
2 Mar 2011 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 7,883 $25.39 $200,149
2 Mar 2011
95,075
1 Mar 2011 Francis M Cuss
SVP Dscvry and Exp Clinl Resrch
Option 25,704 $25.58 $657,508
1 Mar 2011
97,943


Rubius Therapeutics Inc executives and stock owners

Rubius Therapeutics Inc executives and other stock owners filed with the SEC include: